STOCK TITAN

Director at Dolby Laboratories (DLB) sells 1,000 shares, holds 12,541

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Dolby Laboratories director Emily Rollins reported an open-market sale of 1,000 shares of Class A common stock at $60.08 per share on April 1, 2026. After this transaction, she directly holds 12,541 shares of Class A common stock.

Her post-transaction holdings include 3,908 shares underlying restricted stock units that remain subject to forfeiture until they vest, meaning part of her reported position is tied to future service or performance conditions rather than fully vested stock.

Positive

  • None.

Negative

  • None.
Insider Rollins Emily
Role Director
Sold 1,000 shs ($60K)
Type Security Shares Price Value
Sale Class A Common Stock 1,000 $60.08 $60K
Holdings After Transaction: Class A Common Stock — 12,541 shares (Direct)
Footnotes (1)
  1. [object Object]
Shares sold 1,000 shares Open-market sale of Class A Common Stock on April 1, 2026
Sale price $60.08 per share Price for 1,000 shares of Class A Common Stock
Shares held after sale 12,541 shares Direct Class A Common Stock holdings following the transaction
RSU underlying shares 3,908 shares Shares of Class A Common Stock underlying restricted stock units, subject to forfeiture until vesting
open-market sale financial
"reported an open-market sale of 1,000 shares of Class A common stock"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Class A common stock financial
"1,000 shares of Class A common stock at $60.08 per share"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
restricted stock units financial
"3,908 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Form 4 regulatory
"The Form 4 classifies Emily Rollins’ transaction as a sale."
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Rollins Emily

(Last)(First)(Middle)
C/O DOLBY LABORATORIES, INC.
1275 MARKET STREET

(Street)
SAN FRANCISCO CALIFORNIA 94103

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Dolby Laboratories, Inc. [ DLB ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock04/01/2026S1,000D$60.0812,541(1)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Shares held following the reported transaction included 3,908 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
/s/ Daniel Rodriguez as Attorney-in-Fact for Emily Rollins04/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Dolby Laboratories (DLB) director Emily Rollins report on this Form 4?

Emily Rollins reported selling 1,000 shares of Dolby Laboratories Class A common stock in an open-market transaction at $60.08 per share. Following the sale, she holds 12,541 shares, including 3,908 shares underlying restricted stock units that will vest over time.

How many Dolby (DLB) shares does Emily Rollins hold after the reported sale?

After the sale, Emily Rollins directly holds 12,541 shares of Dolby Laboratories Class A common stock. This total includes 3,908 shares underlying restricted stock units, which are subject to forfeiture until they vest under the company’s equity award terms.

At what price did Emily Rollins sell Dolby Laboratories (DLB) shares?

Emily Rollins sold 1,000 shares of Dolby Laboratories Class A common stock at an average price of $60.08 per share. The sale was reported as an open-market transaction under transaction code “S” on the Form 4 insider filing.

What does it mean that some of Emily Rollins’ Dolby (DLB) shares are underlying restricted stock units?

The filing explains that 3,908 of Emily Rollins’ reported Dolby shares are underlying restricted stock units. These RSUs are subject to forfeiture until they vest, so she does not fully own the underlying shares until the vesting conditions are satisfied.

Is Emily Rollins’ Dolby Laboratories (DLB) transaction classified as a buy or a sell?

The Form 4 classifies Emily Rollins’ transaction as a sale. It uses transaction code “S” and describes the action as an open-market sale of 1,000 shares of Dolby Laboratories Class A common stock at $60.08 per share.

Does the Form 4 show any Dolby (DLB) option exercises or derivative transactions by Emily Rollins?

The insider data show no option exercises or derivative transactions for this filing. All reported activity relates to a single non-derivative transaction, an open-market sale of 1,000 shares of Dolby Laboratories Class A common stock held directly by Emily Rollins.